文献速递肝病消化道肿瘤与早癌消化内镜

磁共振成像与超声在原发性硬化性胆管炎中早期检测胆管癌的比较

Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis.
PubMed 文献 · Hepatology · 2021-04-19

该多中心回顾性研究纳入266例原发性硬化性胆管炎(PSC)成人(胆管癌120例),均于3个月内接受超声和磁共振成像(MRI)检查。MRI检测胆管癌的曲线下面积高于超声:全队列0.87对0.70,无症状者0.81对0.59,列入肝移植方案者0.88对0.71。无症状诊断者5年总生存率82%对46%,MRI检测与死亡率降低相关(风险比0.10,95%置信区间0.01-0.96)。

要点

  • MRI检测PSC相关早期胆管癌的曲线下面积优于超声(全队列0.87对0.70)。
  • 无症状诊断胆管癌者5年总生存率82%对46%(对数秩检验P<0.01)。
  • 无症状胆管癌中MRI检测与死亡率降低相关(风险比0.10,95%置信区间0.01-0.96)。

核心结论

  • MRI在检测PSC患者早期胆管癌方面优于超声。
  • 通过MRI在症状出现前识别胆管癌与结局改善相关。

研究设计与样本

  • 多中心回顾性综述,纳入266例原发性硬化性胆管炎成人(胆管癌120例),均于3个月内接受超声和MRI检查。
  • 图像由对临床信息设盲的放射科医生重新审阅。

主要发现

  • MRI检测胆管癌的曲线下面积高于超声:全队列0.87对0.70,无症状个体0.81对0.59,列入胆管癌移植方案者0.88对0.71。
  • 胆管癌诊断时无症状与5年结局改善相关,包括总生存率82%对46%(对数秩检验P<0.01)和肝移植后无复发生存率89%对65%(对数秩检验P=0.04)。
  • 无症状胆管癌患者中,MRI检测(对比超声)与死亡率降低相关(风险比0.10,95%置信区间0.01-0.96),并与移植列入后胆管癌进展风险降低相关(风险比0.10,95%置信区间0.01-0.90)。
  • 在胆管癌诊断前接受年度监测且PSC病程超过1年的患者中,这些获益持续存在。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Early detection of perihilar cholangiocarcinoma (CCA) among patients with primary sclerosing cholangitis (PSC) is important to identify more people eligible for curative therapy. While many recommend CCA screening, there are divergent opinions and limited data regarding the use of ultrasound or magnetic resonance imaging (MRI) for early CCA detection, and it is unknown whether there is benefit in testing asymptomatic individuals. Our aims were to assess the diagnostic performances and prognostic implications of ultrasound and MRI-based CCA detection. APPROACH AND RESULTS: This is a multicenter review of 266 adults with PSC (CCA, n = 120) who underwent both an ultrasound and MRI within 3 months. Images were re-examined by radiologists who were blinded to the clinical information. Respectively, MRI had a higher area under the curve compared with ultrasound for CCA detection: 0.87 versus 0.70 for the entire cohort; 0.81 versus 0.59 for asymptomatic individuals; and 0.88 versus 0.71 for those listed for CCA transplant protocol. The absence of symptoms at CCA diagnosis was associated with improved 5-year outcomes including overall survival (82% vs. 46%, log-rank P < 0.01) and recurrence-free survival following liver transplant (89% vs. 65%, log-rank P = 0.04). Among those with asymptomatic CCA, MRI detection (compared with ultrasound) was associated with reduction in both mortality (hazard ratio, 0.10; 95% confidence interval, 0.01-0.96) and CCA progression after transplant listing (hazard ratio, 0.10; 95% confidence interval, 0.01-0.90). These benefits continued among patients who had annual monitoring and PSC for more than 1 year before CCA was diagnosed. CONCLUSIONS: MRI is superior to ultrasound for the detection of early-stage CCA in patients with PSC. Identification of CCA before the onset of symptoms with MRI is associated with improved outcomes.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Eaton JE, Welle CL, Bakhshi Z, et al. Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis. Hepatology. 2021. PMID: 32974892. doi:10.1002/hep.31575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。